Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,131,301 | -766,409 | -461,203 | -213,416 | -600,093 |
| Depreciation Amortization | -11,273 | -11,421 | -10,042 | -6,101 | -32,741 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -762 |
| Accounts receivable | N/A | N/A | N/A | N/A | 1,254 |
| Accounts payable and accrued liabilities | 9,535 | 20,036 | 491 | -8,270 | -6,465 |
| Other Working Capital | 86,823 | 54,577 | -1,866 | 2,437 | 1,168 |
| Other Operating Activity | 148,475 | 79,714 | 56,428 | 30,915 | 80,203 |
| Operating Cash Flow | $-897,741 | $-623,503 | $-416,192 | $-194,435 | $-557,436 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 134,048 | 57,241 | 29,043 | -12,683 | -544,086 |
| PPE Investments | -15,990 | -14,065 | -10,716 | -3,266 | -10,308 |
| Investing Cash Flow | $118,058 | $43,176 | $18,327 | $-15,949 | $-554,394 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 244,215 | 244,215 | 250,000 | N/A | N/A |
| Common Stock Issued | 377,089 | 11,621 | 7,473 | 892 | 959,129 |
| Other Financing Activity | 220 | 29 | -16 | -18 | 284 |
| Financing Cash Flow | $621,524 | $255,865 | $257,457 | $874 | $959,413 |
| Beginning Cash Position | 546,762 | 546,762 | 546,762 | 546,762 | 699,179 |
| End Cash Position | 388,603 | 222,300 | 406,354 | 337,252 | 546,762 |
| Net Cash Flow | $-158,159 | $-324,462 | $-140,408 | $-209,510 | $-152,417 |
| Free Cash Flow | |||||
| Operating Cash Flow | -897,741 | -623,503 | -416,192 | -194,435 | -557,436 |
| Capital Expenditure | -15,990 | -14,065 | -10,716 | -3,266 | -10,308 |
| Free Cash Flow | -913,731 | -637,568 | -426,908 | -197,701 | -567,744 |